Company Filing History:
Years Active: 2009
Title: The Innovations of Stephen Foster
Introduction
Stephen Foster is an accomplished inventor based in Newbury Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and antibodies.
Latest Patents
Stephen Foster holds a patent for TRAIL receptor-2 polypeptides and antibodies. This patent includes polypeptides that are provided, as well as antibodies or antigen binding domains that bind such polypeptides. The patent also outlines methods for obtaining an antibody that binds tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) Receptor-2 (TR-2). These methods involve administering at least one of the polypeptides to an animal and obtaining an antibody that binds TR-2 from the animal. Additionally, the patent provides antibodies reactive with TR-2, cells producing these antibodies, pharmaceutical compositions comprising them, and methods using these antibodies. Furthermore, it includes kits comprising antibodies reactive with TR-2 and methods for decreasing or preventing the binding of an antibody to TR-2 by administering such a polypeptide.
Career Highlights
Stephen Foster is currently employed at Amgen Inc., a leading biotechnology company. His work focuses on innovative solutions in the field of therapeutic antibodies and their applications in treating various diseases.
Collaborations
Stephen has collaborated with notable colleagues such as Brian Gliniak and Xiao-Dong Yang, contributing to advancements in their shared field of research.
Conclusion
Stephen Foster's work in developing TRAIL receptor-2 polypeptides and antibodies showcases his innovative spirit and dedication to advancing biotechnology. His contributions are significant in the ongoing quest for effective therapeutic solutions.